MedPath

An early phase 2 study of NST-141 in patients with atopic dermatitis

Phase 2
Conditions
Pruritus associated with atopic dermatitis
Registration Number
JPRN-jRCT2080221375
Lead Sponsor
TAIHO PHARMACEUTICAL CO.,LTD, NIPPON SHINYAKU CO.,LTD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
120
Inclusion Criteria

(1) Signed, written informed consent.
(2) Able to be treated as an outpatient.
(3) Diagnosis of atopic dermatitis by Japanese dermatological association criteria.

Exclusion Criteria

(1) Serious asthma.
(2) Hepatic, renal, heart or hematological disease considered to be clinically significant by the Investigator's opinion.
(3) Infection of skin with antimicrobial use.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in levels of pruritus
Secondary Outcome Measures
NameTimeMethod
Pruritus score
© Copyright 2025. All Rights Reserved by MedPath